Review10.1007/s11255-015-1042-9

State-of-the-art biosimilar erythropoietins in the management of renal anemia: lessons learned from Europe and implications for US nephrologists

Adrian Covic,Ivo Abraham-2015-07-29-International Urology and Nephrology

13

Chat with Paper

AI Agents for this Paper

No abstract available for this paper.

Keywords

BiosimilarMedicineErythropoietinPharmacovigilancePharmacologyAnemiaIntensive care medicineInternal medicine

Chat

Click to start Chat